Justin Arter, who previously headed the $62 billion portfolio managed by the Victorian Funds Management Corporation, has taken the role as CEO of industry fund CBUS Super.
RARE Infrastructure Traffic-reliant infrastructure assets have been among the hardest hit during the COVID-19 crisis as global trade and people movement ground to a halt. Yet signs of a tepid recovery are offering some hope for the sector, as the global economy begins its rebound. In this session, RARE Infrastructure puts forward the case to…
The ASX 200 (XJO:ASX) fell 2.0% on Friday, but managed to hold onto a 0.5% gain for the month; it’s fourth straight winning month.
All that glitters, active vs. passive and why a closer look at infrastructure.
The Australian share market and ASX200 (ASX: XJO) finished the week down 0.2%, with the renewed confidence following the extension of the JobKeeper program offset by China’s growing combativeness and weakness in the US technology sector.
Treasurer Frydenberg provided his long-awaited budget update, which was just that an update, offering little in the way of guidance into the future. The Government are predicting unemployment will peak at 9.25% across the country, with ballooning deficits adding $250 billion to the debt pile.
The ASX 200 (ASX:XJO) finished off its lows for the day, falling 1.3%, as both Victoria and several US states hit record COVID-19 case levels, denting market sentiment.
Despite an increasing chorus of experts suggesting the technology sector has moved beyond reasonable levels, the rally continues. The ASX 200 (ASX:XJO) added 2.6%, hitting a six week high, with a 5.7% rally in the IT sector among the largest contributors.
As working from home has become the new normal for most people, there are still many opportunities for advisers and investors to cut through the noise and hear insights from some of the best investment managers and research teams with a range of webinars being hosted online every day.
The ASX 200 (ASX:XJO) continued its recent weakness, falling 0.5% on Monday, as concerns of a secondary outbreak in NSW and escalating deaths in the US hit investor confidence.
